Company: SHPH
Filing Date: 2025-02-26
Form Type: 10-K
Source: 0001493152-25-008300
Chunk: 392

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-02-26
Form: 10-K
Item: Item 1B
Chunk 392
---
 —  
     6,480 
  
    Change in operating lease asset and liabilities 
     286  
     16,001 
  
    Net cash used in operating activities 
     (7,327,230) 
     (5,581,147)

    CASH FLOWS FROM INVESTING ACTIVITIES: 

    Investment in marketable securities 
     (43,587) 
     (2,998,572)
  
    Proceeds from disposition of marketable securities 
     2,959,352  
     187,895 
  
    Purchase of equipment 
     —  
     (19,046)
  
    Net cash provided by (used in) investing activities 
     2,915,765  
     (2,829,723)

    CASH FLOWS FROM FINANCING ACTIVITIES: 

    Proceeds from note payable-related party 
     250,000  
     — 
  
    Repayment of note payable-related party 
     (59,730) 
     (685,473)
  
    Proceeds from convertible notes payable 
     790,000  
     3,935,000 
  
    Proceeds from issuance of common stock, warrants and pre-funded warrants, net of placement agent fees of $504,770 
     3,992,675  
     — 
  
    Payment of other issuance costs for issuance of common stock and equity-classified warrants 
     (235,707) 
     — 
  
    Payment for issuance costs related to liability-classified warrants 
     (28,477) 
     — 
  
    Proceeds from exercise of pre-funded warrants 
     729  
     (345,000)
  
    Payment for convertible notes finance costs 
     (107,491) 
     (334,444)
  
    Payment of convertible note payable 
     (846,806) 
     — 
  
    Net cash provided by financing activities 
     3,755,193  
     2,570,083 

    Net change in cash and cash equivalents 
     (656,272) 
     (5,840,787)
  
    Cash and cash equivalents, beginning of period 
     2,576,416  
     8,417,203 
  
    Cash and cash equivalents, end of period